Contra-indicated for patients at higher risk for G6PD deficiency (e.g. those of African and Mediterranean ancestry) who should be screened due to the risk of hemolysis and methemoglobinemia.
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
PEG-Interferon
ANAPHYLAXIS and INFUSION REACTIONS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
